Pro-inflammatory cytokines simultaneously affect erythropoiesis at several levels, and manifest their effects as ‘inflammation anaemia’ and hyporesponsiveness to EPO treatment in patients with CKD [8]. The gene discussed is EPO; the disease is chronic kidney disease.